Mastectomy News and Research

RSS

Mastectomy is surgery to remove the breast (or as much of the breast tissue as possible).

Liberator Medical Holdings closes private placement of 4.66M common stock shares

Liberator Medical Holdings, Inc. announces today the closing of a private placement of 4,666,667 shares of its common stock for gross proceeds of $7.0 million on March 9, 2010, to a single institutional investor. Littlebanc Advisors, LLC. acted as the sole placement agent and financial advisor to the Company. Liberator's Board of Directors unanimously approved the transaction. As part of the transaction, the institutional investor has the right to add a member of its choice to Liberator Medical's Board of Directors.

11 Mar 2010

Breast cancer patients with early stage disease may not benefit from radiation after mastectomy

Breast cancer patients with early stage disease that has spread to only one lymph node may not benefit from radiation after mastectomy, because of the low present-day risk of recurrence following modern surgery and systemic therapy, a finding that could one day change the course of treatment for thousands of women diagnosed each year, according to researchers at The University of Texas M. D. Anderson Cancer.

7 Mar 2010

PINC trial to test anti-malarial drug in women with DCIS

Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove.

3 Mar 2010

CPM procedure may only offer survival benefit to breast cancer patients age 50 and younger

Contralateral prophylactic mastectomy (CPM), a preventive procedure to remove the unaffected breast in patients with disease in one breast, may only offer a survival benefit to breast cancer patients age 50 and younger, who have early-stage disease and are estrogen receptor (ER) negative, according to researchers at The University of Texas M. D. Anderson Cancer Center.

26 Feb 2010

Unique resource for families facing hereditary breast and ovarian cancer

When she was forty-two, Joi Morris learned that she has a genetic mutation on a gene known as BRCA2. This meant that her risk of getting breast cancer could be as high as 84 percent by age seventy, and that her risk for ovarian cancer was also high.

23 Feb 2010

Stem Cell Assurance performs first regenerative cell breast augmentation surgery

Stem Cell Assurance, Inc. announced today that Arthur Handal, MD., F.A.C.S. has performed the first regenerative cell breast augmentation through its nationwide physician network. The procedure was performed at Handal Plastic Surgery in Boca Raton, Florida in the practice's onsite accredited ambulatory surgical facility.

21 Jan 2010

More than half of women with DCIS are spared a mastectomy

Over 60 per cent of women who have a form of breast cancer in the milk ducts (DCIS) are spared a mastectomy, according to latest research published today in the British Journal of Cancer.

19 Jan 2010

Liberator Medical Holdings reports record net revenues for fiscal year 2009

Liberator Medical Holdings, Inc. announced net revenues for fiscal year 2009 of $25,818,000, representing an increase of $16,268,000, or 170.3%, compared with fiscal year 2008. The increase in sales occurred in the mail order segment of its business. The increase was due to a substantial direct-response advertising campaign to obtain new mail order customers.

18 Dec 2009

Consumer Watchdog calls for preserving state authority, ban on annual benefit limits and effective rate regulation

Consumer Watchdog condemned the removal of the Medicare buy-in provision for those over 55 and the public option from the U.S. Senate health reform bill. But the group said that the Senate must still make three essential fixes to the greatly weakened bill to prevent ceding the entire health care system to the insurance industry.

16 Dec 2009

Additional therapy and screening may be needed for patients with mucinous breast cancer

In a large review of breast cancer patients with mucinous carcinoma, researchers at The University of Texas M. D. Anderson Cancer Center have identified an association between this rare type of breast cancer long-associated with a favorable prognosis and multiple tumors undetected by mammography or ultrasound.

14 Dec 2009

Cell-enriched breast reconstruction procedure improves breast deformity in lumpectomy patients

Interim results from a European clinical trial, RESTORE 2, demonstrate that cell-enriched breast reconstruction achieved a high rate of patient and physician satisfaction and improvements in overall breast deformity in lumpectomy patients.

14 Dec 2009

Medifocus begins common stock trading on OTC Pink Sheets market

Medifocus, Inc., a biotechnology company focused on the commercialization of a proprietary and patented microwave focused heat system for the treatment of breast cancer is pleased to announce that the Company had begun trading its common stock on the OTC Pink Sheets market on Dec. 7, 2009.

10 Dec 2009

Health reform bill: 10 key positive and negative consumer protection provisions

Consumer Watchdog released a list today of the 10 key positive and negative consumer protection provisions of the U.S. Senate health reform bill, HR 3590, which passed an important procedural vote this weekend.

24 Nov 2009

Breastcancer.org opposes proposed new guidelines for mammograms

"The recommendation to change breast screening is a huge step backwards," says Dr. Marisa Weiss, a leading breast oncologist and founder and president of Breastcancer.org.

19 Nov 2009

Radiation breakthrough to treat breast cancer patients in one day arrives at CTCA

A radiation breakthrough to treat breast cancer patients in one day, as opposed to the current average of six weeks, has arrived at Cancer Treatment Centers of America(R) (CTCA) in Philadelphia. CTCA will become the first in the country to offer this treatment option using the Novac7 technology from Rome, Italy.

19 Nov 2009

Enrollment complete in Cytori Therapeutics' international breast cancer reconstruction study

Cytori Therapeutics completed enrollment in a 70-patient, international breast cancer reconstruction study, RESTORE 2. The study is evaluating the use of cell-enriched fat grafting to restore functional and cosmetic deformities in women who have undergone partial mastectomy for early breast cancer.

16 Nov 2009

Novadaq announces financial results for the third quarter of 2009

Novadaq® Technologies Inc., a developer of real-time imaging systems for use in the operating room, today announced 2009 third quarter revenues of $1,723,000 compared to revenue of $3,311,000 in third quarter 2008. In accordance with corporate policy, a previously reported order in excess of $2,000,000 has not been recorded in sales due to cash not yet received.

12 Nov 2009

New breast reconstruction surgery for women

Since her teens, Jennifer Jablon had watched family members deal with breast cancer during their 40s, 50s, and 60s. She wondered whether it would be her fate too.

6 Nov 2009

IMC-RT does not benefit breast cancer patients

After mastectomy, breast cancer patients who receive radiation treatment to the lymph nodes located behind the breast bone do not live longer than those who do not receive radiation to this hard-to-treat area, according to a randomized 10-year study presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

3 Nov 2009

ASTRO to host news briefings on top cancer research papers

The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting.

30 Oct 2009